Enovix (NASDAQ:ENVX) Trading 9% Higher – Here’s What Happened

Enovix Corporation (NASDAQ:ENVX)’s share price traded up 9% on Wednesday . The company traded as high as $6.09 and last traded at $6.0250. 3,564,590 shares traded hands during trading, a decline of 44% from the average session volume of 6,350,229 shares. The stock had previously closed at $5.53.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on ENVX shares. TD Cowen reaffirmed a “buy” rating on shares of Enovix in a research report on Thursday, May 14th. Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Craig Hallum decreased their target price on Enovix from $10.00 to $8.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Wells Fargo & Company set a $6.00 price target on shares of Enovix in a report on Thursday, March 12th. Finally, Bank of America started coverage on shares of Enovix in a research report on Thursday, March 12th. They set a “neutral” rating and a $6.00 price objective on the stock. Seven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Enovix has a consensus rating of “Moderate Buy” and a consensus price target of $12.64.

Enovix Price Performance

The stock has a market cap of $1.46 billion, a PE ratio of -8.06 and a beta of 2.24. The business has a fifty day simple moving average of $5.91 and a two-hundred day simple moving average of $6.91. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14.

Enovix (NASDAQ:ENVX) last released its earnings results on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. The company had revenue of $7.60 million during the quarter, compared to analysts’ expectations of $6.95 million. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The firm’s revenue for the quarter was up 49.1% compared to the same quarter last year. During the same quarter last year, the business posted ($0.15) EPS. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Research analysts forecast that Enovix Corporation will post -0.81 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ENVX. Caitlin John LLC bought a new stake in Enovix during the third quarter worth about $27,000. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Enovix in the 4th quarter worth approximately $30,000. Parallel Advisors LLC grew its stake in shares of Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after buying an additional 1,342 shares during the last quarter. CWM LLC increased its position in Enovix by 95.4% during the 4th quarter. CWM LLC now owns 6,081 shares of the company’s stock valued at $44,000 after buying an additional 2,969 shares in the last quarter. Finally, Calamos Advisors LLC purchased a new position in Enovix during the first quarter valued at $60,000. 50.92% of the stock is currently owned by institutional investors.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.